After a nay from NICE, Scotland says aye to J&J’s Spravato

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

Scotland backs AZ’s Lynparza for first-line ovarian cancer m...

Keeping up the PACE at the Scottish Medicines Consortium (SM...

There are many ways that patient centricity could be delivered when doing a health technology assessment (HTA).

Pfizer's Ibrance available across UK after thumbs up in Scot...

Around 800 women have received the drug for free.

Eisai bemoans UK's north-south cancer divide

Lenvima available in Scotland, not England.

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s...

Sanofi steals a march on rivals Amgen